Baripro BisHb - Iron, Zinc, Folic Acid, & Vit B12 Tablets

BariPro BisHb is film coated small sized tablet that contains ferrous bis-glycinate. This is the most effectively absorbed form of iron in comparison to other types of iron chelate in people with Iron deficiency anaemia. Ferrous bis-glycinate is a non-haem iron that passes through the stomach and small intestine without breaking apart

  • Provides highest Bio-Absorption
  • Less likely to cause intestinal side effects such as nausea, constipation and bloating
  • Does not interact with multivitamins

60 Tablets



  • BisHb is film coated small sized tablet that contains ferrous bis-glycinate. This is the most effectively absorbed form of iron in comparison to other types of iron chelate in people with Iron deficiency anaemia. Ferrous bis-glycinate is a non-haem iron that passes through the stomach and small intestine without breaking apart, thus it-

    • Provides highest Bio-Absorption
    • Holds high Bio-availability even in presence of phytates, tannins, oxalates etc
    • Less likely to cause intestinal side effects such as nausea, constipation and bloating
    • Does not interact with multivitamins
    • Solubility is not affected by changes in pH

    Storage: Store protected from light & moisture, at a temperature not exceeding 25°C.

    Keep out of reach of children.
  • Not to exceed the stated recommended daily usage
  • This product is not intended to diagnose, treat, cure or prevent any disease. In case of accidental overdose contact a physician.
  • NOT FOR MEDICINAL USE.
  • Not to be used by pregnant, nursing and lactating women, without adivse of their physician.
  • POLYOLS MAY HAVE LAXATIVE EFFECTS
  • Recommended Usage : One to two tablets a day or as advised by physician/Dietician.
  • CAUTION: If you have had gastric surgery and experience persistent nausea, vomiting, diarrhea, or other symptoms, contact your healthcare practitioner.

     

  • Iron

    Post-WLS patients at low risk (males and patients without history of anaemia) for post-WLS iron deficiency should receive at least 18 mg of iron from their multivitamin.

    Menstruating females and patients who have undergone RYGB, SG, or BPD/DS should take at least 45–60 mg of elemental iron daily (cumulatively, including iron from all vitamin and mineral supplements).

    Oral supplementation should be taken in divided doses separately from calcium supplements, acid-reducing medications, and foods high in phytates or polyphenols.



Related Items